ESC 365 - Out-of-Hospital Cardiac Arrest due to Refractory Pulseless Ventricular Tachycardia (VT) and/or Ventricular Fibrillation (VF)

ESC Premium Access

Out-of-Hospital Cardiac Arrest due to Refractory Pulseless Ventricular Tachycardia (VT) and/or Ventricular Fibrillation (VF)

Session: Ventricular arrhythmias and sudden cardiac death e-posters

Topic: Management of Out-of-Hospital Cardiac Arrest

Speaker: Doctor S. Uppal (Columbus, US)

Event: ESC Congress 2021 - The Digital Experience

Congress Presentation

About the speaker

Doctor Saurav Uppal

Ohio State University Wexner Medical Center, Columbus (United States of America)

0 follower

38 more presentations in this session

A territory-wide study of arrhythmogenic right ventricular cardiomyopathy patients from Hong Kong

Speaker: Mr I. Lakhani (Hong Kong, HK)

Arrhythmias caused by mutations in SCN5A in children

Speaker: Miss E. Polyakova (Moscow, RU)

Real-world evaluation of follow up strategies after implantable cardiac-defibrillator therapies in patients with ventricular tachycardia (REFINE-VT)

Speaker: Doctor P. Tran (Coventry, GB)

Sex differences in incidence of out-of-hospital cardiac arrest across ethnic and socioeconomic groups: a population-based cohort study in the Netherlands

Speaker: Ms R. Bolijn (Amsterdam, NL)

Socioeconomic data predict adverse cardiovascular outcomes

Speaker: Professor J. Kostis (New Brunswick, US)

Access the full session

Ventricular arrhythmias and sudden cardiac death e-posters

Speakers: Doctor S. Uppal, Mr I. Lakhani, Miss E. Polyakova, Doctor P. Tran, Ms R. Bolijn...

About the event

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress

Related content

ESC Premium Access

Acute myocardial infarction with cardiogenic shock: how I did treat.

29 August 2021

ESC Premium Access

Prognostic significance of different congestion evaluation modalities in acute heart failure patients classified according to left ventricular ejection fraction

28 August 2021

ESC Premium Access

Rethinking therapeutic and diagnostic strategies for chronic coronary syndromes: European and Japanese perspectives after the ISCHEMIA trial – discussion.

27 August 2021

ESC 365 is supported by